The Late Stage Chronic Kidney Disease Drugs Market was valued at US$ 4,680.0 million in 2019 and is projected to reach US$ 11,096.9 million by 2027; it is expected to grow at a CAGR of 11% from 2021 to 2027. End-stage kidney disease, also called end-stage kidney disease, occurs when chronic kidney disease (the gradual loss of […]
